Number of patients per cohort | “Early 2020” (n = 3,221) | “Late 2020” (n = 6,417) | Total (N = 9,638) |
---|---|---|---|
Number of patients per medication | |||
Azithromycin | 2,063 (64.05%) | 3,039 (47.36%) | 5,102 (52.94%) |
Corticosteroids | 2,282 (70.85%) | 6,216 (96.87%) | 8,498 (88.17%) |
Hydroxychloroquine | 1,157 (35.92%) | 82 (1.28%) | 1,239 (12.86%) |
Remdesivir | 834 (25.89%) | 3,290 (51.27%) | 4,124 (42.79%) |
Tocilizumab | 549 (17.04%) | 251 (3.91%) | 800 (8.30%) |